Alnylam Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R.
ALNY Key Statistics
Stock Snapshot
With a market cap of 37.72B, Alnylam Pharmaceuticals(ALNY) trades at $282.35. The stock has a price-to-earnings ratio of 68.76.
As of 2026-06-13, Alnylam Pharmaceuticals(ALNY) stock has fluctuated between $281.77 and $291.39. The current price stands at $282.35, placing the stock +0.2% above today's low and -3.1% off the high.
The Alnylam Pharmaceuticals(ALNY)'s current trading volume is 1.42M, compared to an average daily volume of 1.16M.
During the past year, Alnylam Pharmaceuticals(ALNY) stock moved between $281.77 at its lowest and $495.55 at its peak.
During the past year, Alnylam Pharmaceuticals(ALNY) stock moved between $281.77 at its lowest and $495.55 at its peak.
ALNY News
...
GENESIS Pharma announced the expansion of its longstanding commercial partnership with Alnylam (ALNY) Pharmaceuticals. The extended agreement broadens the geogr...
In early trading on Monday, shares of Marvell Technology topped the list of the day's best performing components of the Nasdaq 100 index, trading up 10.2%. Year...
Analyst ratings
71%
of 31 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.